肝臓移植の世界市場

◆英語タイトル:Liver Transplantation - Global Market Outlook (2015-2022)
◆商品コード:SMRC65118
◆発行会社(調査会社):Stratistics MRC
◆発行日:2016年3月
◆ページ数:129
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single UserUSD4,150 ⇒換算¥460,650見積依頼/購入/質問フォーム
2-5 UserUSD5,250 ⇒換算¥582,750見積依頼/購入/質問フォーム
Global Site LicenseUSD7,500 ⇒換算¥832,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はStratistics MRC社の日本における正規販売代理店です。Stratistics MRC社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、肝臓移植の世界市場について調査・分析し、市場動向、市場規模、市場予測、企業動向などを含め、以下の構成でお届けいたします。

・エグゼクティブサマリー
・序文
・市場動向分析
・ファイブフォース分析(市場環境分析)
・肝臓移植の世界市場:治療種類別分析/市場規模
・肝臓移植の世界市場:エンドユーザー別分析/市場規模
・肝臓移植の世界市場:地域別分析/市場規模
・肝臓移植のアメリカ市場規模予測
・肝臓移植のヨーロッパ市場規模予測
・肝臓移植のアジア市場規模予測
・企業動向
・企業分析
【レポートの概要】

According to Stratistics MRC, the Global Liver Transplantation Market accounted for $XX million in 2015 and is expected to grow at a CAGR of XX% to reach $XX million by 2022. Development in treatments, increasing favoured reimbursement policies, rising incidence of Hepatitis A, B and C are the factors driving the market growth. Sufficient number of liver donors, increasing waiting list to get a new liver and length of hospital stay and its charge are restraining the market. North America leads the market for liver transplantation followed by the European countries. Since, the accessibility of liver donors is limited; the market is not yet well recognized in the developing markets such as India, China and others.
By end user, hospitals and adult liver transplantation centers segments are expected to account for around 50% share in the global liver transplantation market. Based on treatment type, liver transplantation surgery is likely to register more than average CAGR over the forecast period owing to surgical techniques and innovations in living related liver transplantations.

Some of the key players in the market include Conatus Pharmaceuticals Inc., Thompson Surgical, Dompe Farmaceutici S.p.A., Integra Life sciences, Digna Biotech, S.L., Isogenis, Inc., Allosource, RedHill Biopharma Ltd, Aetna and UCLA Transplantation Services.

Type of treatments Covered:
• Post-Surgery Anti-Rejection Treatment
o Sirolimus
o Prednisone
o Tacrolimus
o Azathioprine
o Cyclosporine
o Mycophenolate Mofetil
• Liver Transplantation Surgery

End Users Covered:
• Adult Liver Transplantation Centers
• Ambulatory Surgical Centers
• Hospitals

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
• Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt

What our report offers:

- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

【レポートの目次】

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Emerging Markets

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Liver Transplantation Market, By Treatment Type
5.1 Introduction
5.2 Post-Surgery Anti-Rejection Treatment
5.2.1 Sirolimus
5.2.2 Prednisone
5.2.3 Tacrolimus
5.2.4 Azathioprine
5.2.5 Cyclosporine
5.2.6 Mycophenolate Mofetil
5.3 Liver Transplantation Surgery

6 Global Liver Transplantation Market, By End User
6.1 Introduction
6.2 Adult Liver Transplantation Centers
6.3 Ambulatory Surgical Centers
6.4 Hospitals

7 Global Liver Transplantation Market, By Geography
7.1 North America
7.1.1 US
7.1.2 Canada
7.1.3 Mexico
7.2 Europe
7.2.1 Germany
7.2.2 France
7.2.3 Italy
7.2.4 UK
7.2.5 Spain
7.2.6 Rest of Europe
7.3 Asia Pacific
7.3.1 Japan
7.3.2 China
7.3.3 India
7.3.4 Australia
7.3.5 New Zealand
7.3.6 Rest of Asia Pacific
7.4 Rest of the World
7.4.1 Middle East
7.4.2 Brazil
7.4.3 Argentina
7.4.4 South Africa
7.4.5 Egypt

8 Key Developments
8.1 Agreements, Partnerships, Collaborations and Joint Ventures
8.2 Acquisitions & Mergers
8.3 New Product Launch
8.4 Expansions
8.5 Other Key Strategies

9 Company Profiling
9.1 Conatus Pharmaceuticals Inc.
9.2 Thompson Surgical
9.3 Dompe Farmaceutici S.p.A.
9.4 Integra Life sciences
9.5 Digna Biotech, S.L.
9.6 Isogenis, Inc.
9.7 Allosource
9.8 RedHill Biopharma Ltd.
9.9 Aetna
9.10 UCLA Transplantation Services

List of Tables
Table 1 Global Liver Transplantation Market Outlook, By Region (2013-2022) ($MN)
Table 2 Global Liver Transplantation Market Outlook, By Treatment Type (2013-2022) ($MN)
Table 3 Global Liver Transplantation Market Outlook, By Post-Surgery Anti-Rejection Treatment (2013-2022) ($MN)
Table 4 Global Liver Transplantation Market Outlook, By Sirolimus (2013-2022) ($MN)
Table 5 Global Liver Transplantation Market Outlook, By Prednisone (2013-2022) ($MN)
Table 6 Global Liver Transplantation Market Outlook, By Tacrolimus (2013-2022) ($MN)
Table 7 Global Liver Transplantation Market Outlook, By Azathioprine (2013-2022) ($MN)
Table 8 Global Liver Transplantation Market Outlook, By Cyclosporine (2013-2022) ($MN)
Table 9 Global Liver Transplantation Market Outlook, By Mycophenolate Mofetil (2013-2022) ($MN)
Table 10 Global Liver Transplantation Market Outlook, By Liver Transplantation Surgery (2013-2022) ($MN)
Table 11 Global Liver Transplantation Market Outlook, By End User (2013-2022) ($MN)
Table 12 Global Liver Transplantation Market Outlook, By Adult Liver Transplantation Centers (2013-2022) ($MN)
Table 13 Global Liver Transplantation Market Outlook, By Ambulatory Surgical Centers (2013-2022) ($MN)
Table 14 Global Liver Transplantation Market Outlook, By Hospitals (2013-2022) ($MN)
Table 15 North America Liver Transplantation Market Outlook, By Treatment Type (2013-2022) ($MN)
Table 16 North America Liver Transplantation Market Outlook, By Post-Surgery Anti-Rejection Treatment (2013-2022) ($MN)
Table 17 North America Liver Transplantation Market Outlook, By Sirolimus (2013-2022) ($MN)
Table 18 North America Liver Transplantation Market Outlook, By Prednisone (2013-2022) ($MN)
Table 19 North America Liver Transplantation Market Outlook, By Tacrolimus (2013-2022) ($MN)
Table 20 North America Liver Transplantation Market Outlook, By Azathioprine (2013-2022) ($MN)
Table 21 North America Liver Transplantation Market Outlook, By Cyclosporine (2013-2022) ($MN)
Table 22 North America Liver Transplantation Market Outlook, By Mycophenolate Mofetil (2013-2022) ($MN)
Table 23 North America Liver Transplantation Market Outlook, By Liver Transplantation Surgery (2013-2022) ($MN)
Table 24 North America Liver Transplantation Market Outlook, By End User (2013-2022) ($MN)
Table 25 North America Liver Transplantation Market Outlook, By Adult Liver Transplantation Centers (2013-2022) ($MN)
Table 26 North America Liver Transplantation Market Outlook, By Ambulatory Surgical Centers (2013-2022) ($MN)
Table 27 North America Liver Transplantation Market Outlook, By Hospitals (2013-2022) ($MN)
Table 28 Europe Liver Transplantation Market Outlook, By Treatment Type (2013-2022) ($MN)
Table 29 Europe Liver Transplantation Market Outlook, By Post-Surgery Anti-Rejection Treatment (2013-2022) ($MN)
Table 30 Europe Liver Transplantation Market Outlook, By Sirolimus (2013-2022) ($MN)
Table 31 Europe Liver Transplantation Market Outlook, By Prednisone (2013-2022) ($MN)
Table 32 Europe Liver Transplantation Market Outlook, By Tacrolimus (2013-2022) ($MN)
Table 33 Europe Liver Transplantation Market Outlook, By Azathioprine (2013-2022) ($MN)
Table 34 Europe Liver Transplantation Market Outlook, By Cyclosporine (2013-2022) ($MN)
Table 35 Europe Liver Transplantation Market Outlook, By Mycophenolate Mofetil (2013-2022) ($MN)
Table 36 Europe Liver Transplantation Market Outlook, By Liver Transplantation Surgery (2013-2022) ($MN)
Table 37 Europe Liver Transplantation Market Outlook, By End User (2013-2022) ($MN)
Table 38 Europe Liver Transplantation Market Outlook, By Adult Liver Transplantation Centers (2013-2022) ($MN)
Table 39 Europe Liver Transplantation Market Outlook, By Ambulatory Surgical Centers (2013-2022) ($MN)
Table 40 Europe Liver Transplantation Market Outlook, By Hospitals (2013-2022) ($MN)
Table 41 Asia Pacific Liver Transplantation Market Outlook, By Treatment Type (2013-2022) ($MN)
Table 42 Asia Pacific Liver Transplantation Market Outlook, By Post-Surgery Anti-Rejection Treatment (2013-2022) ($MN)
Table 43 Asia Pacific Liver Transplantation Market Outlook, By Sirolimus (2013-2022) ($MN)
Table 44 Asia Pacific Liver Transplantation Market Outlook, By Prednisone (2013-2022) ($MN)
Table 45 Asia Pacific Liver Transplantation Market Outlook, By Tacrolimus (2013-2022) ($MN)
Table 46 Asia Pacific Liver Transplantation Market Outlook, By Azathioprine (2013-2022) ($MN)
Table 47 Asia Pacific Liver Transplantation Market Outlook, By Cyclosporine (2013-2022) ($MN)
Table 48 Asia Pacific Liver Transplantation Market Outlook, By Mycophenolate Mofetil (2013-2022) ($MN)
Table 49 Asia Pacific Liver Transplantation Market Outlook, By Liver Transplantation Surgery (2013-2022) ($MN)
Table 50 Asia Pacific Liver Transplantation Market Outlook, By End User (2013-2022) ($MN)
Table 51 Asia Pacific Liver Transplantation Market Outlook, By Adult Liver Transplantation Centers (2013-2022) ($MN)
Table 52 Asia Pacific Liver Transplantation Market Outlook, By Ambulatory Surgical Centers (2013-2022) ($MN)
Table 53 Asia Pacific Liver Transplantation Market Outlook, By Hospitals (2013-2022) ($MN)
Table 54 Rest of the World Liver Transplantation Market Outlook, By Treatment Type (2013-2022) ($MN)
Table 55 Rest of the World Liver Transplantation Market Outlook, By Post-Surgery Anti-Rejection Treatment (2013-2022) ($MN)
Table 56 Rest of the World Liver Transplantation Market Outlook, By Sirolimus (2013-2022) ($MN)
Table 57 Rest of the World Liver Transplantation Market Outlook, By Prednisone (2013-2022) ($MN)
Table 58 Rest of the World Liver Transplantation Market Outlook, By Tacrolimus (2013-2022) ($MN)
Table 59 Rest of the World Liver Transplantation Market Outlook, By Azathioprine (2013-2022) ($MN)
Table 60 Rest of the World Liver Transplantation Market Outlook, By Cyclosporine (2013-2022) ($MN)
Table 61 Rest of the World Liver Transplantation Market Outlook, By Mycophenolate Mofetil (2013-2022) ($MN)
Table 62 Rest of the World Liver Transplantation Market Outlook, By Liver Transplantation Surgery (2013-2022) ($MN)
Table 63 Rest of the World Liver Transplantation Market Outlook, By End User (2013-2022) ($MN)
Table 64 Rest of the World Liver Transplantation Market Outlook, By Adult Liver Transplantation Centers (2013-2022) ($MN)
Table 65 Rest of the World Liver Transplantation Market Outlook, By Ambulatory Surgical Centers (2013-2022) ($MN)
Table 66 Rest of the World Liver Transplantation Market Outlook, By Hospitals (2013-2022) ($MN)



【レポートのキーワード】

肝移植、肝臓移植、治療、シロリムス、プレドニゾン、タクロリムス

★調査レポート[肝臓移植の世界市場]販売に関する免責事項
★調査レポート[肝臓移植の世界市場]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆